Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Research article

Did you get any help? A post-hoc secondary analysis of a randomized controlled trial of psychoeducation for patients with antisocial personality disorder in outpatient substance abuse treatment programs

Authors: Birgitte Thylstrup, Sidsel Schrøder, Mats Fridell, Morten Hesse

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

People in treatment for substance use disorder commonly have comorbid personality disorders, including antisocial personality disorder. Little is known about treatments that specifically address comorbid antisocial personality disorder.

Methods

Self-rated help received for antisocial personality disorder was assessed during follow-ups at 3, 9 and 15 months post-randomization of a randomized trial of psychoeducation for people with comorbid substance use and antisocial personality disorder (n = 175).

Results

Randomization to psychoeducation was associated with increased perceived help for antisocial personality disorder. Perceived help for antisocial personality disorder was in turn associated with more days abstinent and higher treatment satisfaction at the 3-month follow-up, and reduced risk of dropping out of treatment after the 3-month follow-up, and perceived help mediated the effects of random assignment on days abstinent at 3-month.follow-up.

Conclusions

Brief psychoeducation for antisocial personality disorder increased patients’ self-rated help for antisocial personality disorder in substance abuse treatment, and reporting having received help for antisocial personality disorder was in turn associated with better short-term outcomes, e.g., days abstinent, dropout from treatment and treatment satisfaction.

Trial registration

ISRCTN registry, ISRCTN67266318, retrospectively registered 17/7/2012.
Appendix
Available only for authorised users
Literature
1.
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders - Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiat. 2004;61(8):807–16.CrossRefPubMed
2.
Toftdahl NG, Nordentoft M, Hjorthoj C. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):129–40.CrossRefPubMed
3.
Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1–13.CrossRefPubMed
4.
Colpaert K, Vanderplasschen W, De Maeyer J, Broekaert E, De Fruyt F. Prevalence and determinants of personality disorders in a clinical sample of alcohol-, drug-, and dual-dependent patients. Subst Use Misuse. 2012;47(6):649–61.CrossRefPubMed
5.
Goldstein RB, Compton WM, Pulay AJ, Ruan WJ, Pickering RP, Stinson FS, et al. Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2007;90(2-3):145–58.CrossRefPubMedPubMedCentral
6.
Vélez-Moreno A, Rojas AJ, Rivera F, Fernández-Calderón F, Torrico-Linares E, Ramírez-López J, et al. The impact of personality disorders and severity of dependence in psychosocial problems. Int J Ment Heal Addict. 2016. doi:10.​1007/​s11469-016-9696-9.
7.
Fridell M, Hesse M. Psychiatric severity and mortality in substance abusers - A 15-year follow-up of drug users. Addict Behav. 2006;31(4):559–65.CrossRefPubMed
8.
Jansson I, Hesse M, Fridell M. Influence of personality disorder features on social functioning in substance-abusing women five years after compulsive residential treatment. Eur Addict Res. 2009;15(1):25–31.CrossRefPubMed
9.
Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. Bmc Psychiatry. 2009;9:6.CrossRefPubMedPubMedCentral
10.
Delgadillo J, Gore S, Ali S, Ekers D, Gilbody S, Gilchrist G, et al. Feasibility randomized controlled trial of cognitive and behavioral interventions for depression symptoms in patients accessing drug and alcohol treatment. J Subst Abuse Treat. 2015;55:6–14.CrossRefPubMed
11.
Watkins KE, Hunter SB, Hepner KA, Paddock SM, de la Cruz E, Zhou AJ, et al. An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment. Arch Gen Psychiat. 2011;68(6):577–84.CrossRefPubMedPubMedCentral
12.
Morley KC, Baillie A, Leung S, Sannibale C, Teesson M, Haber PS. Is specialised, integrated treatment for alcohol use disorder and comorbid anxiety and/or depression better than treatment as usual? Alcohol Clin Exp Res. 2015;39:142a-a.
13.
Daughters SB, Stipelman BA, Sargeant MN, Schuster R, Bornovalova MA, Lejuez CW. The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout. J Subst Abuse Treat. 2008;34(2):157–64.CrossRefPubMed
14.
Thylstrup B, Hesse M. The impulsive lifestyle counseling program for antisocial behavior in outpatient substance abuse treatment. Int J Offender Ther Comp Criminol. 2016;60(8):819–35.CrossRef
15.
Thylstrup B, Schroder S, Hesse M. Psycho-education for substance use and antisocial personality disorder: a randomized trial. BMC Psychiatry. 2015;15:283.CrossRefPubMedPubMedCentral
16.
Thylstrup B, Hesse M. Impulsive lifestyle counseling to prevent dropout from treatment for substance use disorders in people with antisocial personality disorder: A randomized study. Addict Behav. 2016;57:48–54.CrossRefPubMed
17.
Kuramoto-Crawford SJ, Han B, Jacobus-Kantor L, Mojtabai R. Differences in patients’ perceived helpfulness of depression treatment provided by general medical providers and specialty mental health providers. Gen Hosp Psychiat. 2015;37(4):340–6.CrossRef
18.
Lorenzo-Blanco EI, Delva J. Examining lifetime episodes of sadness, help seeking, and perceived treatment helpfulness among US Latino/as. Community Ment Health J. 2012;48(5):611–26.CrossRefPubMed
19.
Sun BC, Adams J, Orav EJ, Rucker DW, Brennan TA, Burstin HR. Determinants of patient satisfaction and willingness to return with emergency care. Ann Emerg Med. 2000;35(5):426–34.CrossRefPubMed
20.
Mojtabai R, Olfson M, Sampson NA, Jin R, Druss B, Wang PS, et al. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011;41(8):1751–61.CrossRefPubMed
21.
Ball SA, Carroll KM, Canning-Ball M, Rounsaville BJ. Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation. Addict Behav. 2006;31(2):320–30.CrossRefPubMed
22.
Smith AH, Norton PJ, McLean CP. Client perceptions of therapy component helpfulness in group cognitive-behavioral therapy for anxiety disorders. J Clin Psychol. 2013;69(3):229–39.CrossRefPubMed
23.
Walters GD. Lifestyle theory. In: Bruinsma G, Weisburd D, editors. Encyclopedia of criminology and criminal justice. New York: Springer; 2014. p. 2937–46.CrossRef
24.
Sheehan DV, Janavs J, Baker R, Harnett-Sheehan K, Knapp E, Sheehan M, et al. MINI - Mini International Neuropsychiatric Interview - English Version 5.0.0 - DSM-IV. J Clin Psychiat. 1998;59:34–57.
25.
Walters GD. Recidivism in released lifestyle change program participants. Crim J Behav. 2005;32(1):50–68.CrossRef
26.
Banerjee P, Duggan C, Huband N, Watson N. Brief psychoeducation for people with personality disorder: A pilot study. Psychol Psychother Theory Res Pract. 2006;79:385–94.CrossRef
27.
Hesse M, Thylstrup B. Reaching out to patients with antisocial personality disorder in substance use disorder treatment: interactions between counsellors and clients in a psycho-educational intervention. Adv Dual Diagn. 2016;9(2/3):97–107.CrossRef
28.
Ellis A, Dryden W. Rational-emotive therapy: An excellent counseling theory for NPs. Nurse Pract. 1987;12(7):16–37.CrossRefPubMed
29.
Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiat. 1997;12(5):224–31.CrossRef
30.
Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiat. 1997;12(5):232–41.CrossRef
31.
Pinninti NR, Madison H, Musser E, Rissmiller D. MINI International Neuropsychiatric Schedule: clinical utility and patient acceptance. Eur Psychiat. 2003;18(7):361–4.CrossRef
32.
Black DW, Gunter T, Loveless P, Allen J, Sieleni B. Antisocial personality disorder in incarcerated offenders: Psychiatric comorbidity and quality of life. Ann Clin Psychiatry. 2010;22(2):113–20.PubMed
33.
Mir J, Kastner S, Priebe S, Konrad N, Strohle A, Mundt AP. Treating substance abuse is not enough: Comorbidities in consecutively admitted female prisoners. Addict Behav. 2015;46:25–30.CrossRefPubMed
34.
Maccio A, Meloni FR, Sisti D, Rocchi MB, Petretto DR, Masala C, et al. Mental disorders in Italian prisoners: results of the REDiMe study. Psychiat Res. 2015;225(3):522–30.CrossRef
35.
Narvaez JCM, Jansen K, Pinheiro RT, Kapczinski F, Silva RA, Pechansky F, et al. Psychiatric and substance-use comorbidities associated with lifetime crack cocaine use in young adults in the general population. Compr Psychiat. 2014;55(6):1369–76.CrossRefPubMed
36.
Rikoon SH, Cacciola JS, Carise D, Alterman AI, McLellan AT. Predicting DSM-IV dependence diagnoses from addiction severity index composite scores. J Subst Abuse Treat. 2006;31(1):17–24.CrossRefPubMed
37.
Diamond PM, Magaletta PR. The short-form Buss-Perry Aggression Questionnaire (BPAQ-SF) - A validation study with federal offenders. Assessment. 2006;13(3):227–40.CrossRefPubMed
38.
Murray-Close D, Ostrov JM, Nelson DA, Crick NR, Coccaro EF. Proactive, reactive, and romantic relational aggression in adulthood: Measurement, predictive validity, gender differences, and association with Intermittent Explosive Disorder. J Psychiatr Res. 2010;44(6):393–404.CrossRefPubMed
39.
De Wilde EF, Hendriks VM. The client satisfaction questionnaire: psychometric properties in a dutch addict population. Eur Addict Res. 2005;11(4):157–62.CrossRefPubMed
40.
Baron RM, Kenny DA. The moderator mediator variable distinction in social psychological-research - conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.CrossRefPubMed
41.
Thoemmes F, Mackinnon DP, Reiser MR. Power analysis for complex mediational designs using Monte Carlo methods. Struct Equ Model. 2010;17(3):510–34.CrossRef
42.
43.
Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–91.CrossRefPubMed
44.
Fritz MS, Kenny DA, MacKinnon DP. The combined effects of measurement error and omitting confounders in the single-mediator model. Multivariate Behav Res. 2016;51(5):681–97.CrossRefPubMed
Metadata
Title
Did you get any help? A post-hoc secondary analysis of a randomized controlled trial of psychoeducation for patients with antisocial personality disorder in outpatient substance abuse treatment programs
Authors
Birgitte Thylstrup
Sidsel Schrøder
Mats Fridell
Morten Hesse
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-1165-2

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue

Research article

Outcomes identified and prioritised by consumers of Partners in Recovery: a consumer-led study

Research article

A process evaluation exploring the lay counsellor experience of delivering a task shared psycho-social intervention for perinatal depression in Khayelitsha, South Africa

Research article

Patients on outpatient commitment orders in Northern Norway

Research article

Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients

Research article

Patient experiences questionnaire for interdisciplinary treatment for substance dependence (PEQ-ITSD): reliability and validity following a national survey in Norway

Study protocol

Protocol for the ENCODE trial: evaluating a novel online depression intervention for persons with epilepsy